Published in Biochem J on February 01, 2004
Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev (2010) 2.44
In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. Integr Biol (Camb) (2009) 2.30
Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment. Cancer Res (2006) 1.50
Direct visualization of protease activity on cells migrating in three-dimensions. Matrix Biol (2008) 1.42
Molecular imaging of activated matrix metalloproteinases in vascular remodeling. Circulation (2008) 1.37
Matrix metalloproteases in head and neck cancer. Head Neck (2006) 1.35
Multiplex detection of protease activity with quantum dot nanosensors prepared by intein-mediated specific bioconjugation. Anal Chem (2008) 1.28
Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon. Mol Imaging (2009) 1.25
Protease-modulated cellular uptake of quantum dots. Nano Lett (2006) 1.19
Activatable molecular systems using homologous near-infrared fluorescent probes for monitoring enzyme activities in vitro, in cellulo, and in vivo. Mol Pharm (2009) 1.13
Comparative assessment of substrates and activity based probes as tools for non-invasive optical imaging of cysteine protease activity. PLoS One (2009) 1.08
Use of fluorescence resonance energy transfer for rapid detection of enteroviral infection in vivo. Appl Environ Microbiol (2006) 1.04
Detection of colorectal adenomas using a bioactivatable probe specific for matrix metalloproteinase activity. Neoplasia (2011) 0.99
Imaging enzymes at work: metabolic mapping by enzyme histochemistry. J Histochem Cytochem (2010) 0.97
Detection of MMP-2 and MMP-9 activity in vivo with a triple-helical peptide optical probe. Bioconjug Chem (2012) 0.96
Chemical biology for understanding matrix metalloproteinase function. Chembiochem (2012) 0.92
In vivo optical imaging of membrane-type matrix metalloproteinase (MT-MMP) activity. Mol Pharm (2011) 0.90
Matrix Metalloproteinase Responsive, Proximity-activated Polymeric Nanoparticles for siRNA Delivery. Adv Funct Mater (2013) 0.87
Dual MMP7-proximity-activated and folate receptor-targeted nanoparticles for siRNA delivery. Biomacromolecules (2014) 0.87
Development of an optimized activatable MMP-14 targeted SPECT imaging probe. Bioorg Med Chem (2008) 0.86
Dendrimers in medical nanotechnology. IEEE Eng Med Biol Mag (2009) 0.86
Near-infrared optical proteolytic beacons for in vivo imaging of matrix metalloproteinase activity. Methods Mol Biol (2010) 0.85
Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool. Transl Oncol (2011) 0.84
Thick-tissue bioreactor as a platform for long-term organotypic culture and drug delivery. Lab Chip (2012) 0.83
3D/4D functional imaging of tumor-associated proteolysis: impact of microenvironment. Methods Enzymol (2012) 0.81
Molecular imaging: 18F-FDG PET and a whole lot more. J Nucl Med Technol (2009) 0.81
NEAR-INFRARED DYES: Probe Development and Applications in Optical Molecular Imaging. Curr Org Synth (2011) 0.81
Imaging aspects of the tumor stroma with therapeutic implications. Pharmacol Ther (2013) 0.81
Molecular Imaging of Proteases in Cancer. Cancer Growth Metastasis (2009) 0.81
Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage. Int J Nanomedicine (2008) 0.80
Comparison of metalloproteinase protein and activity profiling. Anal Biochem (2010) 0.79
Metastasis Research Society-American Association For Cancer Research Joint Conference on Metastasis. Cancer Res (2008) 0.79
Immobilizing reporters for molecular imaging of the extracellular microenvironment in living animals. ACS Chem Biol (2011) 0.79
Synthesis and in vitro efficacy of MMP9-activated NanoDendrons. Mol Pharm (2013) 0.79
Enzymatic- and temperature-sensitive controlled release of ultrasmall superparamagnetic iron oxides (USPIOs). J Nanobiotechnology (2011) 0.79
Evaluation of a triple-helical peptide with quenched FluorSophores for optical imaging of MMP-2 and MMP-9 proteolytic activity. Molecules (2014) 0.78
High-throughput protease activity cytometry reveals dose-dependent heterogeneity in PMA-mediated ADAM17 activation. Integr Biol (Camb) (2015) 0.78
Toward plasmonics-enabled spatiotemporal activity patterns in three-dimensional culture models. Syst Biomed (Austin) (2013) 0.77
Molecular and functional imaging of invasion and metastasis: windows into the metastatic cascade. Cancer Biomark (2010) 0.76
Comparison of several linear fluorophore- and quencher-conjugated oligomer duplexes for stability, fluorescence quenching, and kinetics in vitro and in vivo in mice. Bioconjug Chem (2007) 0.75
Grand challenges in biomaterials. Front Bioeng Biotechnol (2014) 0.75
2-Photon Characterization of Optical Proteolytic Beacons for Imaging Changes in Matrix-Metalloprotease Activity in a Mouse Model of Aneurysm. Microsc Microanal (2016) 0.75
Pathomimetic cancer avatars for live-cell imaging of protease activity. Biochimie (2015) 0.75
Fluorocoxib A enables targeted detection of cyclooxygenase-2 in laser-induced choroidal neovascularization. J Biomed Opt (2016) 0.75
New tools for the quantitative assessment of prodrug delivery and neurotoxicity. Neurotoxicology (2015) 0.75
Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol (2002) 5.73
Molecular imaging. Radiology (2001) 5.67
Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol (2001) 4.99
Amino acid analysis: aqueous dimethyl sulfoxide as solvent for the ninhydrin reaction. J Biol Chem (1968) 4.62
A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol (2001) 4.39
In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med (2001) 4.30
Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci U S A (1997) 3.96
Design and therapeutic application of matrix metalloproteinase inhibitors. Chem Rev (1999) 2.96
Near-infrared optical imaging of protease activity for tumor detection. Radiology (1999) 1.97
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog (1994) 1.92
Optical-based molecular imaging: contrast agents and potential medical applications. Eur Radiol (2002) 1.83
Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res (1994) 1.80
Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol (1998) 1.65
The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis. Cancer Res (1998) 1.60
3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties. Magn Reson Med (2001) 1.49
Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. Cancer Res (2003) 1.43
Rapid identification of highly active and selective substrates for stromelysin and matrilysin using bacteriophage peptide display libraries. J Biol Chem (1995) 1.38
A unique substrate binding mode discriminates membrane type-1 matrix metalloproteinase from other matrix metalloproteinases. J Biol Chem (2002) 1.33
Use of osmotically active agents to alter optical properties of tissue: effects on the detected fluorescence signal measured through skin. Lasers Surg Med (2001) 1.23
Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers. Nucleic Acids Res (2000) 1.16
A unique substrate recognition profile for matrix metalloproteinase-2. J Biol Chem (2001) 1.10
Purification of human matrilysin produced in Escherichia coli and characterization using a new optimized fluorogenic peptide substrate. Arch Biochem Biophys (1995) 1.05
Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin). Biochemistry (1993) 1.04
Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science (2002) 12.29
An improved cyan fluorescent protein variant useful for FRET. Nat Biotechnol (2004) 10.24
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell (2004) 7.61
The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res (2009) 6.83
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell (2008) 6.78
Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA (2003) 6.24
Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol (2002) 5.73
A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med (2009) 4.54
Regulation of corepressor function by nuclear NADH. Science (2002) 3.83
Emerging roles of proteases in tumour suppression. Nat Rev Cancer (2007) 3.81
Group exercise, education, and combination self-management in women with fibromyalgia: a randomized trial. Arch Intern Med (2007) 3.20
Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass. J Mol Cell Cardiol (2009) 2.98
Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet (2004) 2.96
Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion. J Biol Chem (2002) 2.87
The rapid shallow breathing index as a predictor of failure of noninvasive ventilation for patients with acute respiratory failure. Respir Care (2012) 2.74
The learning curve for EUS-guided FNA of pancreatic cancer. Gastrointest Endosc (2004) 2.73
Continuous neuromuscular blockade is associated with decreased mortality in post-cardiac arrest patients. Resuscitation (2013) 2.66
MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell (2005) 2.65
Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg (2007) 2.62
Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas. J Clin Invest (2002) 2.28
High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis (2001) 2.25
Noninvasive two-photon imaging reveals retinyl ester storage structures in the eye. J Cell Biol (2004) 2.24
Widespread climate change in the Himalayas and associated changes in local ecosystems. PLoS One (2012) 2.24
Photoconversion in orange and red fluorescent proteins. Nat Methods (2009) 2.23
Critical role of gap junction coupled KATP channel activity for regulated insulin secretion. PLoS Biol (2006) 2.20
Matrix metalloproteinases in tumor-host cell communication. Differentiation (2002) 2.16
The natural history of extracranial metastasis from glioblastoma multiforme. J Neurooncol (2011) 2.15
Retracted Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex. Proc Natl Acad Sci U S A (2007) 2.09
The other side of MMPs: protective roles in tumor progression. Cancer Metastasis Rev (2007) 2.07
The incidence of lower eyelid malposition after facial fracture repair: a retrospective study and meta-analysis comparing subtarsal, subciliary, and transconjunctival incisions. Plast Reconstr Surg (2009) 2.05
Patient satisfaction in postmastectomy breast reconstruction: a comparative evaluation of DIEP, TRAM, latissimus flap, and implant techniques. Plast Reconstr Surg (2010) 2.02
A method for measuring and modeling the physiological traits causing obstructive sleep apnea. J Appl Physiol (1985) (2011) 2.01
Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. Proc Natl Acad Sci U S A (2006) 1.97
Colonization with multidrug-resistant gram-negative bacteria: prolonged duration and frequent cocolonization. Clin Infect Dis (2009) 1.96
Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours. Epilepsia (2009) 1.96
Amphiregulin exosomes increase cancer cell invasion. Curr Biol (2011) 1.93
Effect of oxygen in obstructive sleep apnea: role of loop gain. Respir Physiol Neurobiol (2008) 1.90
Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis. Proc Natl Acad Sci U S A (2007) 1.89
Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background. Cancer Res (2008) 1.88
Quantitative NAD(P)H/flavoprotein autofluorescence imaging reveals metabolic mechanisms of pancreatic islet pyruvate response. J Biol Chem (2004) 1.84
Pancreatic cancer clinical trials and accrual in the United States. J Clin Oncol (2013) 1.81
Optimization of pairings and detection conditions for measurement of FRET between cyan and yellow fluorescent proteins. Microsc Microanal (2006) 1.78
Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect Immun (2006) 1.75
Imaging pancreatic beta-cells in the intact pancreas. Am J Physiol Endocrinol Metab (2005) 1.74
Modulation of RNA editing by functional nucleolar sequestration of ADAR2. Proc Natl Acad Sci U S A (2003) 1.73
Redox sensor CtBP mediates hypoxia-induced tumor cell migration. Proc Natl Acad Sci U S A (2006) 1.67
Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents. Cancer Res (2010) 1.66
Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction. Diabetes (2007) 1.65
Gap junction coupling and calcium waves in the pancreatic islet. Biophys J (2008) 1.65
Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion. Biochem J (2009) 1.64
Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome. Shock (2008) 1.62
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation (2002) 1.62
Electrical impedance myography as a biomarker to assess ALS progression. Amyotroph Lateral Scler (2012) 1.62
Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer. Cancer Res (2004) 1.62
Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin Cancer Res (2005) 1.59
Mechanisms used to restore ventilation after partial upper airway collapse during sleep in humans. Thorax (2007) 1.58
TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling. Cancer Res (2010) 1.57
Global shifts in protein sumoylation in response to electrophile and oxidative stress. Chem Res Toxicol (2004) 1.57
The influence of aging on pharyngeal collapsibility during sleep. Chest (2007) 1.55
Hot flashes, core body temperature, and metabolic parameters in breast cancer survivors. Menopause (2004) 1.54
Imaging matrix metalloproteinases in cancer. Cancer Metastasis Rev (2008) 1.54
Real-time, multidimensional in vivo imaging used to investigate blood flow in mouse pancreatic islets. J Clin Invest (2008) 1.53
Proteases, extracellular matrix, and cancer: a workshop of the path B study section. Am J Pathol (2004) 1.52
Fluorescent proteins at a glance. J Cell Sci (2011) 1.51
Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment. Cancer Res (2006) 1.50
Optical lock-in detection of FRET using synthetic and genetically encoded optical switches. Biophys J (2008) 1.50
Coenzyme Q10 levels are low and associated with increased mortality in post-cardiac arrest patients. Resuscitation (2012) 1.47
Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction. Circulation (2006) 1.46
Timing is everything-colectomy performed on Monday decreases length of stay. Am J Surg (2013) 1.44
Optical imaging of pancreatic beta cells in living mice expressing a mouse insulin I promoter-firefly luciferase transgene. Genesis (2005) 1.42
Microfluidic glucose stimulation reveals limited coordination of intracellular Ca2+ activity oscillations in pancreatic islets. Proc Natl Acad Sci U S A (2004) 1.40
High-contrast imaging of fluorescent protein FRET by fluorescence polarization microscopy. Biophys J (2004) 1.39
Glucose suppression of glucagon secretion: metabolic and calcium responses from alpha-cells in intact mouse pancreatic islets. J Biol Chem (2010) 1.38
Regulation of beta cell glucokinase by S-nitrosylation and association with nitric oxide synthase. J Cell Biol (2003) 1.37
Connexin-36 gap junctions regulate in vivo first- and second-phase insulin secretion dynamics and glucose tolerance in the conscious mouse. Diabetes (2012) 1.37
Reversal of type 1 diabetes in mice by brown adipose tissue transplant. Diabetes (2012) 1.36
Matrix metalloproteases in head and neck cancer. Head Neck (2006) 1.35
Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Arch Biochem Biophys (2002) 1.35
Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa. Gastroenterology (2003) 1.34
Matrix metalloproteinase inhibition attenuates aortic calcification. Arterioscler Thromb Vasc Biol (2006) 1.34
A protective role for matrix metalloproteinase-3 in squamous cell carcinoma. Cancer Res (2004) 1.32
Intrasequence GFP in class I MHC molecules, a rigid probe for fluorescence anisotropy measurements of the membrane environment. Biophys J (2003) 1.31
Matrix metalloproteinases in colorectal cancer: is it worth talking about? Cancer Metastasis Rev (2004) 1.26
Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer. Cancer Res (2006) 1.26
Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging--comparison with contrast-enhanced MR imaging and pathologic findings. Radiology (2010) 1.26
Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon. Mol Imaging (2009) 1.25
Leptin requires canonical migratory signaling pathways for induction of monocyte and macrophage chemotaxis. Am J Physiol Cell Physiol (2007) 1.25
Host nuclear factor-kappaB activation potentiates lung cancer metastasis. Mol Cancer Res (2008) 1.22
Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis. Arch Pediatr Adolesc Med (2002) 1.21